| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |